The largest database of trusted experimental protocols

Ibitreat slide 6 0

Manufactured by Ibidi

The IbiTreat µ-slide VI 0.4 is a specialized cell culture slide designed for microscopic observations. It features a six-well format with a 0.4 mm channel depth.

Automatically generated - may contain errors

2 protocols using ibitreat slide 6 0

1

DNA Fiber Assay for Replication Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA fiber assay was performed as previously described [25 (link)] with the following modification: 1.5 × 105 A2780 and A2780Cis cells were seeded into 6-well plates. The following day cells were synchronized at the G1/S boundary by 6 µM aphidicolin for 24 h [26 (link)]. Cells were washed 2 times with warm PBS, one time with warm RPMI media, and treated as indicated. During the last hour of drug treatment, cells were labeled with CldU 25 μM (Sigma-Aldrich, C6891) for 30 min and then with 250 μM IdU (Sigma-Aldrich, #I7125) for 30 min. Cells were harvested by trypsinization, resuspended in PBS, and samples were diluted to approximately 7 × 105 cells/mL. Fiber spreading, denaturation, fixation, and staining were performed in ibiTreat µ-slide VI 0.4 (Ibidi, #80606). Fluorescence images were captured using a NikonTi2 fluorescence microscope with the 40× objective (with MilliQ water) with excitation wavelengths of 488 and 568 nm, and analyzed using the ImageJ software. At least 100 unidirectional forks labeled with both CldU and IdU were measured for every condition using Fiji [27 (link),28 (link)]. Antibodies used are listed in Table S1.
+ Open protocol
+ Expand
2

HUVEC Migration Assay with HCMV

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assay was performed as described previously [26 (link), 27 (link)] with the use of ibiTreat µ-slide VI0.4 (ibidi GmbH). The details of instrument setup, recording, and analysis was performed as described in [28 ]. In brief, approximately 4 × 104 human umbilical vein cells/chamber were seeded and treated with BQ788 (100 µM) in the presence or absence of HCMV for 16 hours before the assay. All HUVECs were pretreated with 2 ng/mL tumor necrosis factor α (TNF-α) (R&D Systems, cat.no. 210-TA-005) for 2 hours, except for the untreated cells before the assay. At least 6–10 images of each condition were taken for the analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!